Quaterly Results | Medicamen Biotech Ltd. | R Wadiwala Securities Pvt Ltd

MEDICAMEN BIOTECH LTD.

NSE : MEDICAMEQBSE : 531146ISIN CODE : INE646B01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE491.3060.4 (+14.02 %)
PREV CLOSE (Rs.) 430.90
OPEN PRICE (Rs.) 428.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12595
TODAY'S LOW / HIGH (Rs.)428.90 496.00
52 WK LOW / HIGH (Rs.)356.75 903.5
NSE485.8563.75 (+15.1 %)
PREV CLOSE( Rs. ) 422.10
OPEN PRICE (Rs.) 424.30
BID PRICE (QTY) 485.85 (4989)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 149878
TODAY'S LOW / HIGH(Rs.) 424.30 495.40
52 WK LOW / HIGH (Rs.)355.45 845

Quarterly Results

Quarters
Select year
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
Audited
Net Sales
465.02
435.41
419.43
386.65
Total Expenditure
416.09
388.96
349.92
321.75
PBIDT (Excl OI)
48.93
46.45
69.51
64.90
Other Income
8.30
5.50
3.79
3.46
Operating Profit
57.24
51.95
73.30
68.37
Interest
6.47
9.07
9.57
8.58
Exceptional Items
NA
NA
NA
NA
PBDT
50.77
42.88
63.73
59.79
Depreciation
18.05
18.23
16.91
16.23
Profit Before Tax
32.72
24.65
46.82
43.56
Tax
12.42
9.88
7.36
5.87
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
20.30
14.77
39.46
37.69
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
20.30
14.77
39.46
37.69
Minority Interest
NA
7.53
2.30
1.21
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
20.30
22.30
41.77
38.90
Equity Capital
126.51
126.51
126.51
126.51
Face Value (IN RS)
10.00
10.00
10.00
10.00
Reserves
NA
NA
NA
NA
Calculated EPS
1.60
1.76
3.30
3.07
Calculated EPS (Annualised)
6.42
7.05
13.21
12.30
No of Public Share Holdings
7185005.00
7185005.00
7185005.00
7185005.00
% of Public Share Holdings
56.79
56.79
56.79
56.79
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
10.52
10.67
16.57
16.79
PBIDTM%
12.31
11.93
17.48
17.68
PBDTM%
10.92
9.85
15.19
15.46
PBTM%
7.04
5.66
11.16
11.27
PATM%
4.37
3.39
9.41
9.75
 
Notes
Notes
Notes
Notes